Vireo Systems, Inc.
Records under this name other than the patents Vireo Systems, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 8 of 8 · Back to Vireo Systems, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,058,655 | Compositions and methods for treatment of inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,354,450 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Term ended Ended no later than Aug 24, 2024 · Medium confidence | Term ended | Ended no later than Aug 24, 2024 | Medium confidence |
| US 8,962,685 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Term ended Ended no later than May 14, 2024 · Low confidence | Term ended | Ended no later than May 14, 2024 | Low confidence |
| US 9,486,424 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Term ended Ended no later than May 14, 2024 · Medium confidence | Term ended | Ended no later than May 14, 2024 | Medium confidence |
| US 9,962,352 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Term ended Term ended May 14, 2024 · Medium confidence | Term ended | Term ended May 14, 2024 | Medium confidence |
| US 10,881,630 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Formerly held Term ended Term ended May 14, 2024 · Medium confidence | Term ended | Term ended May 14, 2024 | Medium confidence |
| US 8,026,385 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Lapsed on the fee record Ended Sep 27, 2023 · High confidence | Lapsed on the fee record | Ended Sep 27, 2023 | High confidence |
| US 10,342,771 | Creatine Oral Supplementation Using Creatine Hydrochloride Salt Formerly held Lapsed on the fee record Ended Jul 9, 2023 · High confidence | Lapsed on the fee record | Ended Jul 9, 2023 | High confidence |